[1]Actapoloniaepharmaceutica,2015,vol.72,p.89-99
833460-92-7
3245-53-2
50912-60-2
103857-79-0
1094702-92-7
3245-54-3
34955-25-4 | N-(Pyridin-3-yl)hydrazinecarbothioamide | AA007GJG | MFCD03869992
32194-76-6 | 3-(Methoxymethyl)benzoic acid | AA007GZM | MFCD01871355
330-72-3 | 1,1,1-Trifluoro-3-phenylpropan-2-ol | AA007HDE | MFCD00178722
329794-28-7 | 2-Chloro-3-fluoro-4-formylpyridine | AA007HYH | MFCD06657826
15332-10-2 | DFB | AA007IE9 | MFCD03653615
31572-04-0 | 2-Hydroxy-2-methylbut-3-enoic acid | AA007IWE | MFCD09030063
314291-83-3 | PTP Inhibitor V, PHPS1 | AA007JCW | MFCD01079012
29976-54-3 | Methyl 4-oxopiperidine-1-carboxylate | AA007JUV | MFCD11129088
27471-43-8 | 1-(4-Bromophenyl)piperidin-2-one | AA007KLA | MFCD04037064
28163-64-6 | (R)-(+)-Beta-methylphenethylamine | AA007L5I | MFCD00216740